Monday, May 22, 2017 2:29:06 PM
https://www.sec.gov/Archives/edgar/data/1530766/000118518517000698/biosigtech10k123116.htm
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our directors and officers, and persons who own more than ten percent of our common stock, to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock. To our knowledge, based solely on a review of the copies of such reports furnished to us, during the fiscal year ended December 31, 2016, there were a number of transactions that were not timely reported.
The following is the number of late reports since the beginning of the fiscal year ended December 31, 2016, under Section 16(a) and the number of transactions reflected therein as not reported on a timely basis during such fiscal year by such executive officers, directors and persons who own more than ten percent of our common stock:
·
Mr. Londoner failed to file 93 Form 4 filings for approximately 292 transactions in shares of our common stock executed on various dates between January 1, 2016 and February 28, 2017.
·
Mr. Zeldis filed one late report with respect to one transaction.
·
Mr. Weild filed one late report with respect to one transaction.
·
Mr. Tanaka filed one late report with respect to one transaction.
·
Mr. Cash filed two late reports, each with respect to one transaction.
·
Mr. Foley filed one late report with respect to one transaction.
·
Ms. Mikolaitis filed one late report with respect to one transaction.
·
Mr. Chaussy filed two late reports, one with respect to one transaction and one with respect to three transactions.
Recent BSGM News
- BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent • GlobeNewswire Inc. • 05/03/2024 04:22:00 PM
- BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately • GlobeNewswire Inc. • 04/30/2024 06:03:14 PM
- BioSig Engages Consulting Firm for Business Model Strategies • GlobeNewswire Inc. • 04/04/2024 03:35:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 01:00:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 01:04:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:00:37 PM
- BioSig Announces Reduction of its Workforce • GlobeNewswire Inc. • 02/20/2024 03:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:31:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:35:41 PM
- BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases • GlobeNewswire Inc. • 02/06/2024 01:30:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/02/2024 10:18:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 10:25:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:05:24 PM
- BioSig Announces Reverse Stock Split • GlobeNewswire Inc. • 01/31/2024 04:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:52:08 PM
- BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy • GlobeNewswire Inc. • 01/30/2024 01:30:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 01/16/2024 09:15:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 10:28:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 04:00:29 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/05/2024 09:16:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:45 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/29/2023 06:37:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:30 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/28/2023 09:05:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 09:30:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM